LEM-mR203
/ Lemonex
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 07, 2025
Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
(clinicaltrials.gov)
- P1 | N=20 | Completed | Sponsor: Lemonex | Recruiting ➔ Completed | Trial primary completion date: Mar 2024 ➔ Mar 2025
Trial completion • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
December 07, 2023
Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Lemonex | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
September 11, 2023
Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Lemonex
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1